Clearside Biomedical, Inc.·4

Jun 4, 5:13 PM ET

Raymond Brion S. 4

4 · Clearside Biomedical, Inc. · Filed Jun 4, 2019

Insider Transaction Report

Form 4
Period: 2019-05-31
Raymond Brion S.
Chief Commercial Officer
Transactions
  • Award

    Common Stock

    2019-05-31+50,00050,000 total
Footnotes (1)
  • [F1]These shares are represented by restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. The shares underlying this restricted stock unit award will vest in full on May 31, 2020, subject to the Reporting Person's continuous service with the Issuer as of such vesting date, and subject to accelerated vesting in specified circumstances.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION